✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 富马酸伊布利特

富马酸伊布利特

CAS 122647-32-9C20H36N2O3SMW 384.6

富马酸伊布利特,CAS 登记号 122647-32-9,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号122647-32-9
分子式C20H36N2O3S
分子量384.6
LogP4.6
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 富马酸伊布利特 的 CAS 号?

本页已列出 富马酸伊布利特 的 CAS 号:122647-32-9,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

富马酸伊布利特 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Ibutilide fumarate · CAS 122647-32-9 · C20H36N2O3S. UNII 2436VX1U9B. Solubility: 100; Solubility: 4.73e-03 g/L; LogP: 4.6.

Identification

CAS Registry Number122647-32-9
PubChem CID60753
Molecular formulaC20H36N2O3S
IUPAC nameN-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
UNII (FDA)2436VX1U9B

Computed Descriptors

Molecular Weight384.6
XLogP34
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count14
Exact Mass384.24466419
Monoisotopic Mass384.24466419
Topological Polar Surface Area78
Heavy Atom Count26
Formal Charge0

Physical & Chemical Properties

Solubility100
Solubility4.73e-03 g/L
LogP4.6

Physical description & handling notes

  • Solid
  • MW: 885.23. Crystals from acetone, mp 117-119 °C.; UV max (95% ethanol): 228, 267 nm (epsilon 16670, 894); solubility: (mg/mL): aqueous >100 (pH less than or equal to 7) /Ibutilide fumarate/
  • Parenteral: Injection, for IV infusion: 1 mg (0.1 mg/mL), Covert (Pfizer). /Ibutilide fumarate/

Documented Uses

  • The synthesis starts with a Friedel-Crafts acylation of methanesulfonanilide with succinic anhydride in presence of AlCl3 yielding 4-[(methylsulfonyl)amino]-gamma-oxobenzenebutanoic acid, which is treated with N-ethylheptylamine and dicyclohexylcarbodiimide (DCC) in DMF to give the corresponding amide. Reduction with LiAlH4 in THF in the last step provides the desired drug substance.
  • Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.
  • Ibutilide is a class III antiarrhythmic medication approved by the US Food and Drug Administration (FDA) for converting acute atrial flutter and atrial fibrillation to normal sinus rhythm. Research indicates ibutilide's greater efficacy in treating atrial flutter compared to atrial fibrillation.
  • Ibutilide fumarate injection is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Patients with atrial arrhythmias of longer duration are less likely to respond to ibutilide fumarate injection. The effectiveness of ibutilide has not been determined in patients with arrhythmias of more than 90 days in duration. /Included in US product label/
  • Ibutilide is administered as a rapid infusion (1 mg over 10 minutes) for the immediate conversion of atrial fibrillation or flutter to sinus rhythm. The drug's efficacy rate is higher in patients with atrial flutter (50-70%) than in those with atrial fibrillation (30-50%). In atrial fibrillation, the conversion rate is lower in those in whom the arrhythmia has been present for weeks or months compared with those in whom it has been present for days.
  • Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatments to maintain sinus rhythm carry risks. Patients to be treated with ibutilide fumarate injection, therefore, should be carefully selected such that the expected benefits of maintaining sinus rhythm outweigh the immediate risks of ibutilide fumarate injection, and the risks of maintenance therapy, and are likely to offer an advantage compared with alternative management.

Synonyms

Ibutilide; 122647-31-8; Ibutilida; Ibutilidum; n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide; N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide; N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide; 2436VX1U9B; DTXSID20861271; N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide; N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide; RefChem:56518; C01BD05; DTXCID30197270; Ibutilidum [INN-Latin]; Ibutilida [INN-Spanish]

Frequently Asked Questions

What are the CAS number and molecular formula of Ibutilide fumarate?

CAS 122647-32-9; molecular formula C20H36N2O3S; molecular weight — g/mol.

What other names is Ibutilide fumarate known by?

Ibutilide, 122647-31-8, Ibutilida, Ibutilidum, n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide, N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide.

What are the key physical properties of Ibutilide fumarate?

Solubility: 100; Solubility: 4.73e-03 g/L; LogP: 4.6.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 富马酸伊布利特 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1